Aldosterone-salt Hypertensive Rats -acetyl-seryl-aspartyl-lysyl-proline on the Heart and Kidney in N Antifibrotic Effects Of

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats.

  2000cited by this paper
• In vivo assessment of captopril selectivity of angiotensin I-converting enzyme inhibition: differential inhibition of acetyl-ser-asp-lys-pro and angiotensin I hydrolysis.

  1999cited by this paper
• Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.

  1999cited by this paper
• Effect of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats.

  1999cited by this paper
• Nitric oxide synthase activity and renal injury in genetic hypertension.

  1998cited by this paper
• High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition.

  1997cited by this paper
• Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

  1997cited by this paper
• Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat.

  1997cited by this paper
• Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.

  1996cited by this paper
• The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting Enzyme (*)

  1995cited by this paper
• Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction.

  1995cited by this paper
• Collagen remodeling after myocardial infarction in the rat heart.

  1995cited by this paper
• Progression of heart failure: A role for interstitial fibrosis

  1995cited by this paper
• Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone.

  1995cited by this paper
• Mineralocorticoids, hypertension, and cardiac fibrosis.

  1994cited by this paper
• Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.

  1994cited by this paper
• The pathophysiology of obstructive nephropathy: the role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney

  1994cited by this paper
• Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors.

  1993cited by this paper
• Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.

  1993cited by this paper
• Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.

  1993cited by this paper
• PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.

  1991cited by this paper
• In vivo effect of the tetrapeptide, N‐Acetyl‐Ser‐Asp‐Lys‐Pro, on the G1‐S transition of rat hepatocytes

  1990cited by this paper
• Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay.

  1990cited by this paper
• Remodeling of the rat right and left ventricles in experimental hypertension.

  1990cited by this paper
• Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure.

  1989cited by this paper
• Plasma kinin concentration in deoxycorticosterone-salt hypertension.

  1988cited by this paper
• Griffonia simplicifolia I: fluorescent tracer for microcirculatory vessels in nonperfused thin muscles and sectioned muscle.

  1988cited by this paper
• Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ

  1987cited by this paper
• Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues

  1987cited by this paper
• A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion.

  1986cited by this paper
• Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats.

  1984cited by this paper

• Investigating the antifibrotic potential of N‐acetyl seryl‐aspartyl‐lysyl‐proline sequence peptides

  2021cites this paper
• Small Endogeneous Peptide Mitigates Myocardial Remodeling in a Mouse Model of Cardioselective Galectin-3 Overexpression

  2021cites this paper
• Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice

  2020cites this paper
• Thymosin 4-Ac-SDKP pathway: Any relevance for the cardiovascular system?

  2019cites this paper
• Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?

  2019cites this paper
• The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ACE inhibition, and its therapeutic potential in hypertension and cardiovascular diseases.

  2018cites this paper
• N‐acetyl‐seryl‐aspartyl‐lysyl‐proline mediates the anti‐fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice

  2018cites this paper
• Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.

  2017cites this paper
• Effects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosis

  2017cites this paper
• Effects of N‐acetyl‐seryl‐asparyl‐lysyl‐proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus

  2017cites this paper
• Engineered phage nanofibers induce angiogenesis.

  2017cites this paper
• Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure

  2016cites this paper
• Ac-SDKP suppresses TNF-α-induced ICAM-1 expression in endothelial cells via inhibition of IκB kinase and NF-κB activation.

  2016cites this paper
• Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step

  2016cites this paper
• Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells.

  2016cites this paper
• Sodium tanshinone IIA sulfonate attenuates the transforming growth factor-β1-induced differentiation of atrial fibroblasts into myofibroblasts in vitro.

  2015cites this paper
• The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis

  2015cites this paper
• Synthesis and biological screening of small molecule peptides based on the amino acid sequence of thymosin β4

  2015cites this paper
• N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.

  2015cites this paper
• Mediators of Inflammation: Inflammation in Cancer, Chronic Diseases, and Wound Healing

  2015cites this paper
• The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients

  2015cites this paper
• N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice

  2015cites this paper
• Title N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice

  2015cites this paper
• N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes

  2014influential citation
• Ac-SDKP suppresses epithelial-mesenchymal transition in A549 cells via HSP27 signaling.

  2014cites this paper
• Combination Treatment With N-Acetyl-Seryl-Aspartyl-Lysyl-Proline and Tissue Plasminogen Activator Provides Potent Neuroprotection in Rats After Stroke

  2014cites this paper
• N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.

  2014cites this paper
• A Novel Angiotensin I-Converting Enzyme Mutation (S333W) Impairs N-Domain Enzymatic Cleavage of the Anti-Fibrotic Peptide, AcSDKP

  2014cites this paper
• N-acetyl-Ser-Asp-Lys-Pro inhibits interleukin-1β-mediated matrix metalloproteinase activation in cardiac fibroblasts

  2013cites this paper
• A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme

  2013cites this paper
• Antifibrotic peptide N‐acetyl‐Ser‐Asp‐Lys‐Pro (Ac‐SDKP): Opportunities for angiotensin‐converting enzyme inhibitor design

  2013cites this paper
• Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.

  2013cites this paper
• Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis

  2013cites this paper
• Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart

  2012cites this paper
• Nontraditional roles of angiotensin-converting enzyme.

  2012cites this paper
• Prolyl Oligopeptidase as a Drug Target

  2012cites this paper
• RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN CHRONIC KIDNEY DISEASE

  2012cites this paper
• Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats.

  2012cites this paper
• Pathophysiology of the aging kidney and therapeutic interventions

  2012cites this paper
• ДИСФУНКЦИЮ ЭНДОТЕЛИЯ БОЛЬНЫХ НА ПРОГРАММНОМ ГЕМОДИАЛИЗЕ THE INFLUENCE OF SPIRONOLACTONE THERAPY ON THE LEVEL OF ALDOSTERONE AND DYSFUNCTION OF THE ENDOTHELIUM IN PROGRAMMED HEMODIALYSIS PATIENTS

  2012cites this paper
• N-Acetyl–seryl–aspartyl–lysyl–proline inhibits ET-1-induced collagen production by preserving Src homology 2-containing protein tyrosine phosphatase-2 activity in cardiac fibroblasts

  2012cites this paper
• Structure-Based Design of Domain-Selective Angiotensin-Converting Enzyme Inhibitors

  2012cites this paper
• СПИРОНОЛАКТОНОМ CONCENTRATION OF ALDOSTERONE, STATE OF HEMOSTASIS ANВ ENDOTHELIAL FUNCTION IN PATIENTS ON PROGRAMMED HEMODIALYSIS AND EFFECTS OF EXPOSURE TO THERAPY WITH SPIRONOLACTONE

  2012cites this paper
• Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors

  2011cites this paper
• Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner

  2011cites this paper
• TRB 3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model

  2011cites this paper
• TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model

  2011cites this paper
• Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate–salt hypertensive mice

  2011cites this paper
• Papel do sistema renina angiotensina sobre as adaptações eritropoiéticas induzidas pelo treinamento físico aeróbico

  2011cites this paper
• Significance of active site residues in the n-domain selectivity of angiotensin-converting enzyme

  2011cites this paper
• AcSDKP inhibits the proliferation and collagen expression of cardiac fibroblasts induced by PDGF through blocking the ERK1/2 and JNK pathway activation

  2011cites this paper
• A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.

  2011cites this paper
• Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.

  2010cites this paper
• Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.

  2010cites this paper
• N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Attenuates Renal Injury and Dysfunction in Hypertensive Rats With Reduced Renal Mass: Council for High Blood Pressure Research

  2010cites this paper
• Intrapericardial procedures for cardiac regeneration by stem cells

  2010cites this paper
• N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.

  2010cites this paper
• Biological activities of thymosin ß4 defined by active sites in short peptide sequences

  2010cites this paper
• N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.

  2009cites this paper
• The Role of Na+-H+ Exchanger Isoform 1 in Aldosterone-Induced Glomerulosclerosis in Vivo

  2009cites this paper
• Investigating the domain specificity of phosphinic inhibitors RXPA380 and RXP407 in angiotensin-converting enzyme.

  2009cites this paper
• Differential Effects of 17β-Estradiol and of Synthetic Progestins on Aldosterone-Salt–Induced Kidney Disease

  2009cites this paper
• Benefits of ACE Inhibitors in Diabetes

  2009cites this paper
• Antihypertrophic effect of hemin in deoxycorticosterone acetate-salt-induced hypertensive rat model

  2009cites this paper
• Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression

  2008cites this paper
• ACE Inhibitors: A Novel Treatment for Neurofibroma

  2008cites this paper
• Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.

  2008cites this paper
• Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.

  2008influential citation
• Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.

  2008cites this paper
• Effect of intraurethral captopril gel on the recurrence of urethral stricture after direct vision internal urethrotomy: A novel molecular mechanism

  2008cites this paper
• Response to Inflammation, Angiotensin II, and Hypertension

  2008cites this paper
• Decreased Endogenous Levels of Ac-SDKP Promote Organ Fibrosis

  2007cites this paper
• Rationale for combining blockers of the renin-angiotensin system.

  2007cites this paper
• Characterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblasts.

  2007cites this paper
• Role of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline in the Antifibrotic and Anti-Inflammatory Effects of the Angiotensin-Converting Enzyme Inhibitor Captopril in Hypertension

  2007cites this paper
• N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.

  2006cites this paper
• Effects of Enalapril, Tempol, and Eplerenone on Salt-Induced Hypertension in Dahl Salt-Sensitive Rats

  2006cites this paper
• Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.

  2006cites this paper
• Novel mechanism of action of ACE and its inhibitors.

  2005cites this paper
• Angiotensin-Converting Enzyme Inhibitors: A New Mechanism of Action

  2005cites this paper
• Alterations in Aldosterone and Angiotensin II Levels in Salt-Induced Hypertension

  2005cites this paper
• Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.

  2005cites this paper
• Targets for Pharmacological Modulation of Cardiac Fibrosis

  2005cites this paper
• and Function in Hypertensive Rats Reduction of Cardiac Fibrosis Decreases Systolic Performance Without Affecting Diastolic

  2004cites this paper
• Ac-SDKP Reverses Inflammation and Fibrosis in Rats With Heart Failure After Myocardial Infarction

  2004cites this paper
• Hypertensive heart disease and fibrosis

  2004cites this paper
• Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKP

  2004cites this paper
• Reduction of Cardiac Fibrosis Decreases Systolic Performance Without Affecting Diastolic Function in Hypertensive Rats

  2004cites this paper
• Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension

  2004cites this paper
• Possible Contributions of Reactive Oxygen Species and Mitogen-Activated Protein Kinase to Renal Injury in Aldosterone/Salt-Induced Hypertensive Rats

  2004cites this paper
• Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.

  2004cites this paper
• Increased Myocardial Collagen Content in Transgenic Rats Overexpressing Cardiac Angiotensin-Converting Enzyme Is Related to Enhanced Breakdown of N-Acetyl-Ser-Asp-Lys-Pro and Increased Phosphorylation of Smad2/3

  2004cites this paper
• N-Acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells.

  2003cites this paper
• Demonstration of altered fibroblast contractile activity in hypertensive heart disease.

  2003cites this paper
• Ac-SDKP Reverses Cardiac Fibrosis in Rats With Renovascular Hypertension

  2003cites this paper
• Aldosterone-induced cardiac damage: focus on blood pressure independent effects.

  2003cites this paper
• Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases.

  2003cites this paper
• Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease: the potential of exploring the mechanisms of response variability

  2002cites this paper
• Tissue Angiotensin-Converting Enzyme Activity Plays an Important Role in Pressure Overload–Induced Cardiac Fibrosis in Rats

  2002cites this paper
• Angiotensin I‐Converting Enzyme And Metabolism Of The Haematological Peptide N‐Acetyl‐Seryl‐Aspartyl‐Lysyl‐Proline

  2001cites this paper